ArticleJCEM case reports2025
Hypoosmolar Hyponatremia as Presenting Symptom of a Rare Case of Olfactory Neuroblastoma.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyponatremia is a common electrolyte disturbance. The syndrome of inappropriate antidiuresis (SIAD), characterized by nonosmotic release of arginine vasopressin, is a typical cause of hyponatremia. Ectopic secretion of arginine vasopressin by a tumor is often associated with small cell lung cancer but can also be seen in other neoplasms. We present a rare case of a previously healthy 34-year-old woman, evaluated for refractory hypoosmolar hyponatremia consistent with SIAD. After excluding other causes of SIAD, imaging revealed contrast-enhancing mucosal thickening in the left maxillary sinus with expansion into the sphenoid and frontal sinuses, leading to the diagnosis of olfactory neuroblastoma. After surgical removal, hyponatremia resolved. Although treatment of olfactory neuroblastoma typically involves surgery and radiotherapy, there are no standardized therapeutic guidelines, due to the low prevalence of the disease. In summary, olfactory neuroblastoma is an extremely rare paraneoplastic cause of SIAD that should not be overlooked after excluding other possible etiologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.